Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDQ.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.3.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LM.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.63.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDQ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.35SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.9.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.47.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.1.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KU.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JQ.2.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LA.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
LN.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.16.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.57.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.44.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.58.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.86.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDD.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
DR.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
FP.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.39.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.5.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.15.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XCBSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.15.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.40SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.68SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.25SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.46SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used